PL374775A1 - Przyspieszenie metabolizmu alkoholu - Google Patents

Przyspieszenie metabolizmu alkoholu

Info

Publication number: PL374775A1
Authority: PL; Poland
Prior art keywords: alcohol; glyceric acid; complexes; metabolism; nadh
Prior art date: 2002-10-14

Application number

PL03374775A

Other languages

English (en)

Inventor

Pekka Heino

Original Assignee

Remedal Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-14

Filing date

2003-10-13

Publication date

2005-10-31

2003-10-13 Application filed by Remedal Ltd filed Critical Remedal Ltd

2005-10-31 Publication of PL374775A1 publication Critical patent/PL374775A1/pl

Links

LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 9
230000004060 metabolic process Effects 0.000 title abstract 4
RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 abstract 5
RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 abstract 5
101710088194 Dehydrogenase Proteins 0.000 abstract 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
230000003647 oxidation Effects 0.000 abstract 3
238000007254 oxidation reaction Methods 0.000 abstract 3
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 abstract 2
238000006243 chemical reaction Methods 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
230000002708 enhancing effect Effects 0.000 abstract 2
150000002148 esters Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 abstract 1
230000002411 adverse Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000008030 elimination Effects 0.000 abstract 1
238000003379 elimination reaction Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical class C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Addiction (AREA)
Hematology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Lubricants (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL03374775A 2002-10-14 2003-10-13 Przyspieszenie metabolizmu alkoholu PL374775A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FI20021819A FI20021819A0 (fi)	2002-10-14	2002-10-14	Valmiste alkoholin metabolian tehostamiseksi

Publications (1)

Publication Number	Publication Date
PL374775A1 true PL374775A1 (pl)	2005-10-31

Family

ID=8564745

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03374775A PL374775A1 (pl)	2002-10-14	2003-10-13	Przyspieszenie metabolizmu alkoholu

Country Status (14)

Country	Link
US (1)	US7666909B2 (pl)
EP (1)	EP1562576B1 (pl)
JP (1)	JP2006507268A (pl)
KR (1)	KR100693628B1 (pl)
CN (1)	CN100459975C (pl)
AT (1)	ATE330594T1 (pl)
AU (1)	AU2003268987B2 (pl)
CA (1)	CA2501543C (pl)
DE (1)	DE60306410T2 (pl)
ES (1)	ES2270074T3 (pl)
FI (1)	FI20021819A0 (pl)
PL (1)	PL374775A1 (pl)
RU (1)	RU2343911C2 (pl)
WO (1)	WO2004035040A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101166538B (zh) *	2005-05-02	2011-05-18	Cj第一制糖株式会社	用于预防和治疗酒后病的组合物
US7611739B2 (en) *	2006-01-06	2009-11-03	Amerilab Technologies, Inc.	Method of using guava extract and composition including guava extract
DE102011001768A1 (de)	2011-04-04	2012-10-04	Gunnar Frank	Präparat oder Nahrungsergänzungsmittel
US9161957B2 (en)	2012-08-03	2015-10-20	Life Well Lived, Llc	Compositions and methods for reducing blood alcohol content
EA030485B1 (ru)	2013-04-29	2018-08-31	Харша Чигурупати	Спиртные напитки с пониженной гепатотоксичностью
EP3043788B1 (en)	2013-09-13	2023-06-07	Replicon Health OY	D-glyceric acid or dl-glyceric acid for use in the treatment of degeneration diseases related to aging
CN115998722A (zh) *	2023-02-08	2023-04-25	内蒙古金达威药业有限公司	一种解酒保肝组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4450153A (en) *	1982-09-30	1984-05-22	Phillips Petroleum Company	Alcohol removal from blood with alcohol oxidase
JP2936233B2 (ja) *	1990-09-10	1999-08-23	有限会社野々川商事	新規美白化粧料
RU2072239C1 (ru) *	1991-01-11	1997-01-27	Институт биохимии СО РАМН	Способ коррекции метаболической зависимости от алкоголя и средство л.е.панина для его осуществления
ATE177629T1 (de) *	1991-04-10	1999-04-15	Yu Ruey J	Verwendung von 2-hydroxycarbonsäure oder deren derivaten enthaltende zusammensetzung zur linderung von wechseln nagelveränderungen
EP0617958A4 (de) *	1992-07-06	1995-09-06	Irina Alexeevna Komissarova	pharmazeutische Zusammensetzung zur Behandlung von Alkoholismus, zur Stimulierungvon Katabolismus und Magensekretion und zumSchutze gegen Strahlenbeschädigung und Cholera.
AU721728B2 (en) *	1995-04-06	2000-07-13	Baxter International Inc.	Monoisomeric glyceryl tri (chiral alkanoate) compositions and method of making same
US6117868A (en) *	1998-09-16	2000-09-12	Ed. Geistlich Sohne Ag Fur Chemische Industrie	Treatment of gastrointestinal ulcers or gastritis caused by microbial infection

2002
- 2002-10-14 FI FI20021819A patent/FI20021819A0/fi unknown
2003
- 2003-10-13 WO PCT/FI2003/000757 patent/WO2004035040A1/en not_active Ceased
- 2003-10-13 DE DE60306410T patent/DE60306410T2/de not_active Expired - Lifetime
- 2003-10-13 JP JP2004544334A patent/JP2006507268A/ja active Pending
- 2003-10-13 AU AU2003268987A patent/AU2003268987B2/en not_active Ceased
- 2003-10-13 PL PL03374775A patent/PL374775A1/pl unknown
- 2003-10-13 ES ES03750763T patent/ES2270074T3/es not_active Expired - Lifetime
- 2003-10-13 CA CA002501543A patent/CA2501543C/en not_active Expired - Fee Related
- 2003-10-13 AT AT03750763T patent/ATE330594T1/de not_active IP Right Cessation
- 2003-10-13 RU RU2005113980/15A patent/RU2343911C2/ru not_active IP Right Cessation
- 2003-10-13 KR KR1020057006373A patent/KR100693628B1/ko not_active Expired - Fee Related
- 2003-10-13 CN CNB2003801014124A patent/CN100459975C/zh not_active Expired - Fee Related
- 2003-10-13 EP EP03750763A patent/EP1562576B1/en not_active Expired - Lifetime
2005
- 2005-04-13 US US11/105,022 patent/US7666909B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2003268987B2 (en)	2005-11-03
CA2501543C (en)	2008-08-19
US7666909B2 (en)	2010-02-23
EP1562576A1 (en)	2005-08-17
CN100459975C (zh)	2009-02-11
JP2006507268A (ja)	2006-03-02
CN1705476A (zh)	2005-12-07
US20050182135A1 (en)	2005-08-18
CA2501543A1 (en)	2004-04-29
EP1562576B1 (en)	2006-06-21
DE60306410T2 (de)	2007-06-14
KR100693628B1 (ko)	2007-03-14
WO2004035040A1 (en)	2004-04-29
KR20050050671A (ko)	2005-05-31
DE60306410D1 (de)	2006-08-03
RU2343911C2 (ru)	2009-01-20
AU2003268987A1 (en)	2004-05-04
RU2005113980A (ru)	2006-01-20
ATE330594T1 (de)	2006-07-15
ES2270074T3 (es)	2007-04-01
FI20021819A0 (fi)	2002-10-14

Similar Documents

Publication	Publication Date	Title
CN1049334C (zh)	2000-02-16	脂肪酸药剂的新用途
NZ597193A (en)	2014-01-31	Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
TWI314452B (en)	2009-09-11	Amino acid composition and supplemental solution
JP2021504476A (ja)	2021-02-15	非ラセミ体のベータ−ヒドロキシブチレート化合物及びｒ−エナンチオマー富化組成物並びに使用方法
NZ627238A (en)	2016-02-26	Stable pharmaceutical composition comprising ethyl eicosapentaenoate
US20050271739A1 (en)	2005-12-08	Methods and compositions for accelerating alcohol metabolism
WO2003072111A3 (en)	2004-03-18	Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression
WO2006086108A3 (en)	2007-01-11	Use of inhibitors of soluble epoxide hydrolase to synergize activity of cox and 5-lox inhibitors
PL374775A1 (pl)	2005-10-31	Przyspieszenie metabolizmu alkoholu
LU83869A1 (fr)	1982-05-07	Procede de preparation d'une composition pharmaceutique comprenant de la gamma-butyrobetaine pour le traitement de syndromes provoques par une deficience en l-carmitine
WO2006000867B1 (en)	2006-05-18	Compositions for topical treatment
US20150374660A1 (en)	2015-12-31	Ascorbate Esters of Omega-3 Fatty Acids and Their Formulations and Uses
CN113197884A (zh)	2021-08-03	α-酮丁酸在制备预防和/或治疗非酒精性脂肪肝的药物中的应用
JPH07285881A (ja)	1995-10-31	アルコール代謝促進剤
Kasemset et al.	1984	Regulation of Mn-SOD activity in the mouse heart: Glucose effect
FR2531632A1 (fr)	1984-02-17	Produits pharmaceutiques avec action cytostatique, a base d'esters d'acides gras
EP1875906A3 (en)	2008-02-27	Therapeutic use of yessotoxins as human tumor cell growth inhibitors
JP2005132766A (ja)	2005-05-26	光動力学的癌治療薬
US12527847B1 (en)	2026-01-20	Compositions and methods for reducing blood ethanol concentration through alcohol dehydrogenase and acetaldehyde scavengers
Khan-Siddiqui	2018	Lysine-carnitine conversion in rat and man
WO2020246807A3 (ko)	2021-01-21	나프토퀴논 화합물을 포함하는 암 치료용 약학적 조성물
FR2897534A1 (fr)	2007-08-24	Utilisation du tesaglitazar pour la preparation d'une composition pharmaceutique destinee au traitement des affections dermatologiques
UA94693C2 (ru)	2011-06-10	Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, которые страдают сердечно-сосудистым заболеванием
HK1031174B (en)	2006-04-21	Compositions and methods for treating diabetes
HK1031174A1 (en)	2001-06-08	Compositions and methods for treating diabetes

Legal Events

Date	Code	Title	Description
2012-02-29	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)